Kizil Lab will deliver a speech entitled “Models of Amyloid Toxicity and Neural Stem Cell Plasticity in Adult Zebrafish and 3D Human Neural Progenitor Cell Cultures“ and chair a discussion on “The Suitability of Animal Models for Preclincal Studies” in Boston on June 19th at the World Pre-clinical Congress, which is a key event on preclinical research and translational medicine across all therapeutic areas.
Cambridge Healthtech Institute’s CNS Disease Models brings together leading drug discovery and preclinical scientists to discuss the latest developments in animal models, induced pluripotent stem cells (iPSCs) and human embryonic stem cells (hESCs) for neurodegenerative, psychiatric and neurological disorders as well as the critical factors that affect the variability and reproducibility of these models.
Kizil Lab 